Overview

Corticosteroid Therapy of Septic Shock - Corticus

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether steroids decrease 28-day mortality in patients with septic shock.
Phase:
Phase 3
Details
Lead Sponsor:
Hadassah Medical Organization
Collaborators:
European Society of Intensive Care Medicine
International Sepsis Forum
The Gorham Foundation
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate